References
- American Urological Association. American Urological Association Guideline: Management of Benign Prostatic Hyperplasia(BPH). American Urology Association Education and Research, Inc. 2010 : 2-8.
- AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). chapter 1: Diagnosis and treatment recommendations. J Urol. 2003 ; 170 : 530-47 https://doi.org/10.1097/01.ju.0000078083.38675.79
- The Korean Urological Association. The Urology. Seoul : Korea Medical Box Publisher. 2001 : 307-9.
- Wei J, Calhoun E, Jacobsen S. Urologic disease in America project: benign prostatic hyperplasia. J Urol. 2005 ; 173(4) : 1256-61. https://doi.org/10.1097/01.ju.0000155709.37840.fe
- McConnell J, Roehrborn C, Bautista O et al. Benign prostatic hyperplasia: maintaining symptom control and reducing complications. Urology. 2003 ; 62(3 Supple 1) : 15-23.
- Lee HG, Park YI, Jo SR. Clinical results of transurethral Electro-Vaporization of the prostate. Korean J Urol. 2001 ; 42(8) : 804-8.
- Amy E Krambeck, Shelly E Handa, James E Lingeman. Experience with more than 1,000 Holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol. 2013 ; 189(4) : 1415-20. https://doi.org/10.1016/j.juro.2012.10.002
- Doo HK. Donguisingyehag. Seoul : Seongbosa. 2003 : 705-8.
- Doo HK. Imsangsingyehagyeongu. Seoul : Seongbosa. 1995 : 452.
- Hyun MK, Sin WY, Choi EY et al. A case of intractable hiccup treated with Paljung-san. J Korean Orient Int Med. 2005 ; 25(2) : 506-11.
- Kim SM, Yoo DY. A case report of the effect of Paljeongsna on the female urethral syndrome. Korean J Obstet Gynecol. 2007 ; 20(4) : 225-33.
- Song MK, Park SH, Kang JS et al. Report of four cases of Paljung-san on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Korean Oriental Med. 2010 ; 31(1) : 153-61.
- Lim CY, Kim MH, Lee GS et al. Beneficial effect of Paljeong-san pharmacopuncture treatment combined with peritoneal injection on Glycerolinduced acute renal failure in rabbits. J Korean Pharm Sci. 2010 ; 13(3) : 73-80.
- Lee SY, Kim MH, Cho SI et al. The effect of Paljeong-San pharmacopuncture treatment on Glycerol-induced acute renal failure in rats. The Journal of Daejeon Oriental Medicine. 2012 ; 21(1) : 163-74.
- Korean Society for Sexual Medicine and Andrology. Textbook of Andrology. Seoul : Koonja. 2003 ; 542, 557-65.
- Hong SJ. Benign prostatic hyperplasia: Multiple factors for prostate tissue change with aging. Korean J Urol. 2005 ; 46(6) : 547-54.
- Lee DH, Lee JS, Kim YS. The effects of Lygodium japonicum on experimental rat model of benign prostatic hyperplasia. J Korean Orient Int Med. 2010 ; 31(3) : 457-66.
- Paloma AM, Clemens B, Angelika R et al. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. PNAS. 2009 ; 106(8) : 2859-63. https://doi.org/10.1073/pnas.0812666106
- Chung BH. Medical management for benign prostatic hyperplasia. Korean J Urol. 2007 ; 48(3) : 233-43. https://doi.org/10.4111/kju.2007.48.3.233
- Carson C III, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003 ; 61(4 Supple 1) : 2-7.
- Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5 alphareductase inhibition in human benign prostatic hyperplasia. World J Urol. 2002 ; 19(6) : 413-25. https://doi.org/10.1007/s00345-002-0248-5
- Woo JH, Kang JY, Kim EK et al. The effect of short term dutasteride therapy on microvessel density in benign prostatic hyperplasia. Korean J Urol. 2008 ; 49(6) : 515-9. https://doi.org/10.4111/kju.2008.49.6.515
- Lourenco T, Pcickard R, Vale L et al. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. BMJ. 2008 ; 337 : a1662. https://doi.org/10.1136/bmj.a1662
- Doo HK. Donguisingyehagyeongu. Seoul : Kyung Hee University Press. 1994 : 359.
- Jin S. Taepyeonghyeminhwajegugbang. Taipei : Seonpung Publisher. 1984 : 175.
- Heo J. Donguibogam. Seoul : Donguibogam. 2010 :
- Professors of Department of Formula Science in College of Korean Medicine. Formula Science. Seoul : Yeongnimsa. 1999 : 497.
- Committee on Compilation of Textbook of Korean Society for Acupuncture & Moxibustion. Acupuncture & Moxibustion. Paju : Jipmoondang Publishing Company. 2008 : 306.
- Rim HK, Rim JS, Moon HB. A Study on the Relationship between Histologic Composition and Clinical Symptoms in Benign Prostatic Hyperplasia. Korean J Urol. 1994 ; 35(3) : 230-6.
- McNeal JE. The prostate and prostatic urethra: a morphologic synthesis. J Urol. 1972 ; 107(6) : 1008-16.
- McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol. 1978 ; 15(4) : 340-5.
- Kim JG, Cho KS, Ahn HJ. The Evaluation of Correlation between the Histologic Composition of BPH and TRUS Findings. Korean J Urol. 1998 ; 39(1) : 51-6.
- Jung SI, Oh BR, Ryu SB. Assessing the Effect of Finasteride by Prostate Tissue Composition. Korean J Urol. 2001 ; 42(12) : 1278-83.
-
Chae SJ, Song HS. The Effects of Cobrotoxin on NF-
$\kappa{B}$ Activation in Human Prostatic Cancer Cell Line(PC-3). J Korean Acupuncture & Moxibustion Medicine Society. 2005 ; 22(5) : 37-48. - Yang CY, Song HS. Bee Venom Inhibits Prostate Cancer Growth in LNCaP Xenografts via Apoptosis. J Pharmacopuncture. 2010 ; 13(1) : 15-35.
-
Shin JM, Song HS. Bee Venom Inhibits DU-145 Human Prostate Cancer Cell Growth Through Inactivation of NF-
${\kappa}B$ . J Korean Acupuncture & Moxibustion Society. 2011 ; 28(3) : 101-10. -
Oh HJ, Song HS. Bee Venom Inhibits PC-3 Cell Proliferation Through Induction of Apoptosis Via Inactivation of NF-
${\kappa}B$ . J Korean Acupuncture & Moxibustion Society. 2010 ; 27(3) : 1-13. - Hur KY, Song HS. Bee Venom Inhibits DU-145 Cell Proliferation Through Induction of Apoptosis. J Korean Acupuncture & Moxibustion Society. 2011 ; 28(3) : 111-9.